Year archive

Genmab — 2022 filings

All 190 regulatory filings released by Genmab (GMAB) in 2022, sourced directly from the official regulator.

190 Filings

2022 Period

2022 filings (190)

Filing	Released	Lang
6-K Foreign Filer Report	2022-12-14	English
Director's Dealing 2022 Director's Dealing	2022-12-14	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-12-14	English
6-K Foreign Filer Report	2022-12-14	English
6-K Foreign Filer Report	2022-12-13	English
Director's Dealing 2022 Director's Dealing	2022-12-13	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-12-13	Danish
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-12-13	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-12-13	Danish
6-K Foreign Filer Report	2022-11-29	English
6-K Foreign Filer Report	2022-11-23	English
Director's Dealing 2022 Director's Dealing	2022-11-23	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-11-23	Danish
6-K Foreign Filer Report	2022-11-21	English
Director's Dealing 2022 Director's Dealing	2022-11-21	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-11-21	English
6-K Foreign Filer Report	2022-11-16	English
6-K Foreign Filer Report	2022-11-15	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-11-15	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-11-15	Danish
6-K Foreign Filer Report	2022-11-14	English
Director's Dealing 2022 Director's Dealing	2022-11-14	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-11-14	Danish
6-K Foreign Filer Report	2022-11-09	English
6-K Foreign Filer Report	2022-11-03	English
Earnings Release 2022 Earnings Release FY 2022	2022-11-03	English
Genmab Improves Its 2022 Financial Guidance Earnings Release FY 2022	2022-11-03	English
6-K Foreign Filer Report	2022-10-18	English
Earnings Release 2022 Earnings Release Q3 2022	2022-10-18	English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Third Quarter of 2022 Earnings Release Q3 2022	2022-10-18	English
6-K Foreign Filer Report	2022-10-05	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-10-05	English
Major Shareholder Announcement Major Shareholding Notification	2022-10-05	English
6-K Foreign Filer Report	2022-09-28	English
6-K Foreign Filer Report	2022-09-27	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-09-27	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-09-27	English
6-K Foreign Filer Report	2022-09-26	English
6-K Foreign Filer Report	2022-09-20	English
6-K Foreign Filer Report	2022-09-01	English
Regulatory Filings 2022 Regulatory Filings	2022-09-01	English
Completion of share buy-back program Transaction in Own Shares	2022-09-01	English
Completion of share buy-back program Transaction in Own Shares	2022-09-01	Danish
6-K Foreign Filer Report	2022-08-29	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-08-29	English
Transactions in connection with share buy-back program Regulatory Filings	2022-08-29	Danish
Transactions in connection with share buy-back program Transaction in Own Shares	2022-08-29	Danish
6-K Foreign Filer Report	2022-08-24	English
Director's Dealing 2022 Director's Dealing	2022-08-24	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-08-24	English
6-K Foreign Filer Report	2022-08-22	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-08-22	English
Transactions in connection with share buy-back program Regulatory Filings	2022-08-22	Danish
Transactions in connection with share buy-back program Transaction in Own Shares	2022-08-22	Danish
6-K Foreign Filer Report	2022-08-17	English
Director's Dealing 2022 Director's Dealing	2022-08-17	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-08-17	Danish
6-K Foreign Filer Report	2022-08-17	English
6-K Foreign Filer Report	2022-08-16	English
Director's Dealing 2022 Director's Dealing	2022-08-16	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-08-16	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-08-16	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-08-16	Danish
6-K Foreign Filer Report	2022-08-15	English
Regulatory Filings 2022 Regulatory Filings	2022-08-15	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-08-15	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-08-15	Danish
6-K Foreign Filer Report	2022-08-10	English
Earnings Release 2022 Earnings Release H1 2022	2022-08-10	English
Genmab Announces Financial Results for the First Half of 2022 Report Publication Announcement H1 2022	2022-08-10	Danish
6-K Foreign Filer Report	2022-08-08	English
Earnings Release 2022 Earnings Release H1 2022	2022-08-08	English
Genmab Improves Its 2022 Financial Guidance Earnings Release FY 2022	2022-08-08	Danish
6-K Foreign Filer Report	2022-08-08	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-08-08	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-08-08	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-08-08	Danish
6-K Foreign Filer Report	2022-08-02	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-08-02	English
Major Shareholder Announcement Major Shareholding Notification	2022-08-02	English
6-K Foreign Filer Report	2022-08-01	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-08-01	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-08-01	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-08-01	Danish
6-K Foreign Filer Report	2022-07-25	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-07-25	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-07-25	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-07-25	English
6-K Foreign Filer Report	2022-07-20	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-07-20	English
Major Shareholder Announcement Major Shareholding Notification	2022-07-20	Danish
6-K Foreign Filer Report	2022-07-19	English
Earnings Release 2022 Earnings Release Q2 2022	2022-07-19	English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2022 Earnings Release Q2 2022	2022-07-19	English
6-K Foreign Filer Report	2022-07-18	English
Regulatory Filings 2022 Regulatory Filings	2022-07-18	English
Genmab Announces That AbbVie Will Submit Marketing Authorization Application to European Medicines Agency for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Diffuse Large B-C Regulatory Filings	2022-07-18	English
6-K Foreign Filer Report	2022-07-18	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-07-18	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-07-18	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-07-18	Danish
6-K Foreign Filer Report	2022-07-11	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-07-11	English
Major Shareholder Announcement Major Shareholding Notification	2022-07-11	Danish
6-K Foreign Filer Report	2022-07-11	English
Regulatory Filings 2022 Regulatory Filings	2022-07-11	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-07-11	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-07-11	Danish
6-K Foreign Filer Report	2022-07-06	English
6-K Foreign Filer Report	2022-07-05	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-07-05	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-07-05	Danish
6-K Foreign Filer Report	2022-07-05	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-07-04	English
Transactions in connection with share buy-back program Regulatory Filings	2022-07-04	Danish
Transactions in connection with share buy-back program Transaction in Own Shares	2022-07-04	Danish
6-K Foreign Filer Report	2022-07-01	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-07-01	English
Major Shareholder Announcement Major Shareholding Notification	2022-07-01	English
6-K Foreign Filer Report	2022-06-30	English
Regulatory Filings 2022 Regulatory Filings	2022-06-30	English
Genmab to Submit Biologics License Application to U.S. Food and Drug Administration for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) Regulatory Filings	2022-06-30	English
6-K Foreign Filer Report	2022-06-27	English
Declaration of Voting Results & Voting Rights Announcements 2022 Declaration of Voting Results & Voting Rights Announcements	2022-06-27	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-06-27	English
Transactions in connection with share buy-back program Transaction in Own Shares	2022-06-27	English
6-K Foreign Filer Report	2022-06-23	English
Director's Dealing 2022 Director's Dealing	2022-06-23	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-06-23	English
6-K Foreign Filer Report	2022-06-21	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-06-20	English
Major Shareholder Announcement Major Shareholding Notification	2022-06-20	English
6-K Foreign Filer Report	2022-06-17	English
Transaction in Own Shares 2022 Transaction in Own Shares	2022-06-17	English
Genmab Announces Initiation of Share Buy-Back Program Transaction in Own Shares	2022-06-17	English
6-K Foreign Filer Report	2022-06-16	English
6-K Foreign Filer Report	2022-06-09	English
Legal Proceedings Report 2022 Legal Proceedings Report	2022-06-09	English
Genmab Commences New Arbitration Under License Agreement With Janssen Legal Proceedings Report	2022-06-09	English
6-K Foreign Filer Report	2022-06-09	English
6-K Foreign Filer Report	2022-06-01	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-06-01	English
Major Shareholder Announcement Major Shareholding Notification	2022-06-01	English
6-K Foreign Filer Report	2022-05-18	English
6-K Foreign Filer Report	2022-05-17	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-05-17	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-05-17	English
6-K Foreign Filer Report	2022-05-11	English
6-K Foreign Filer Report	2022-04-19	English
Earnings Release 2022 Earnings Release Q1 2022	2022-04-19	English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2022 Earnings Release Q1 2022	2022-04-19	English
6-K Foreign Filer Report	2022-04-13	English
Regulatory Filings 2022 Regulatory Filings	2022-04-13	English
Genmab and AbbVie Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) From Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL) Regulatory Filings	2022-04-13	Danish
6-K Foreign Filer Report	2022-04-08	English
Legal Proceedings Report 2022 Legal Proceedings Report	2022-04-08	English
Genmab Announces the Initial Resolution of its Arbitration with Janssen Relating to their Daratumumab License Agreement Regulatory Filings	2022-04-08	Danish
6-K Foreign Filer Report	2022-04-07	English
6-K Foreign Filer Report	2022-03-29	English
Director's Dealing 2022 Director's Dealing	2022-03-29	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-03-29	English
6-K Foreign Filer Report	2022-03-29	English
6-K Foreign Filer Report	2022-03-14	English
6-K Foreign Filer Report	2022-03-09	English
6-K Foreign Filer Report	2022-02-25	English
Director's Dealing 2022 Director's Dealing	2022-02-25	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-02-25	English
REGISTRATION STATEMENT Registration Form	2022-02-24	English
6-K Foreign Filer Report	2022-02-24	English
6-K Foreign Filer Report	2022-02-23	English
6-K Foreign Filer Report	2022-02-22	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-02-22	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2022-02-22	Danish
20-F Annual Report FY 2021	2022-02-16	English
6-K Foreign Filer Report	2022-02-16	English
Report Publication Announcement 2022 Report Publication Announcement	2022-02-16	English
Genmab Publishes 2021 Annual Report Annual Report (ESEF) FY 2021	2022-02-16	English
Genmab Publishes 2021 Annual Report Regulatory Filings	2022-02-16	Danish
6-K Foreign Filer Report	2022-02-03	English
Major Shareholding Notification 2022 Major Shareholding Notification	2022-02-03	English
6-K Foreign Filer Report	2022-01-26	English
Director's Dealing 2022 Director's Dealing	2022-01-26	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-01-26	English
6-K Foreign Filer Report	2022-01-25	English
6-K Foreign Filer Report	2022-01-25	English
Earnings Release 2021 Earnings Release FY 2021	2022-01-25	English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2021 Earnings Release FY 2021	2022-01-25	English
6-K Foreign Filer Report	2022-01-04	English
Director's Dealing 2022 Director's Dealing	2022-01-04	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2022-01-04	English

Filings by year

2026 64 filings
2025 190 filings
2024 204 filings
2023 149 filings
2022 190 filings
2021 226 filings
2020 167 filings
2019 213 filings
2018 68 filings
2017 124 filings
2016 229 filings
2015 128 filings
2014 107 filings
2013 132 filings
2012 98 filings
2011 97 filings
2010 133 filings
2009 121 filings
2008 109 filings
2007 70 filings